Records containing: Pertussis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-03-04Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
-
CLINICAL_TRIALS study record update · 2020-01-10Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System Through a Randomized Trial
-
CLINICAL_TRIALS study record update · 2020-01-02Phase Ib (High Dose), Single Centre, Dose-escalating, Placebo-controlled, Randomized Study of a Live Attenuated B. Pertussis Strain Given as a Single Intranasal Dose to Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2019-11-26Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda-a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2019-11-14CD8 Reactivity to Microorganisms in Blood and Breast Milk
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-10-24Impact of Pertussis Vaccination in Pregnancy on Maternal Protection Offered to Young Infants
-
CLINICAL_TRIALS study record update · 2019-10-24Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand
-
CLINICAL_TRIALS study record update · 2019-10-16Evaluation of Tdap in Pregnancy to Prevent Infant Pertussis
-
CLINICAL_TRIALS study record update · 2019-10-03Antibody Persistence at 2 Years After a Single Dose Vaccination of Acellular Pertussis Vaccines Among Thai Adolescents
-
CLINICAL_TRIALS study record update · 2019-10-01Antibody Persistence at 3 Years After a Single Dose Vaccination of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin
-
CLINICAL_TRIALS study record update · 2019-09-06A Multi-center, Randomized, Active-controlled, Parallel-group, Open-label and Phase II Study to Evaluate Immunogenicity and Safety of LBVD (Fully Liquid Hexavalent Vaccine; Adsorbed Diphtheria-Tetanus-Pertussis-Hepatitis B- Inactivated Poliomyelitis (Sabin) and Haemophilus Influenzae Type b Conjugate Vaccine) Compared to Co-administration of EupentaTM Inj. and Imovax® Polio (Poliomyelitis Vaccine (Inactivated)) in Separate Injections in Healthy Infants at 6-10-14 Weeks of Age as Primary Series
-
CLINICAL_TRIALS study record update · 2019-08-29A Single-center, Randomized, Active-controlled, Parallel-group, Open-label, Phase I Study to Evaluate Safety and Immunogenicity of Single Injection of LBVD or Eupenta Co-administered With Imovax Polio in Healthy Adults
-
CLINICAL_TRIALS study record update · 2019-08-14A Prospective, Open-label, Interventional Phase IV Study to Assess the Safety of EupentaTM Inj. {Fully Liquid Pentavalent Vaccine, Adsorbed Diphtheria-Tetanus-whole-cell Pertussis-Hepatitis B (rDNA [Recombinant-deoxyribonucleic Acid])-Haemophilus Influenzae Type b Conjugate Vaccine}
-
CLINICAL_TRIALS study record update · 2019-08-09Bordetella Pertussis Infection Among Adolescents and Adults With Prolonged Cough
-
CLINICAL_TRIALS study record update · 2019-07-19Immunogenicity and Safety of GSK Biologicals' Combined Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus and Haemophilus Influenzae Type b (DTPa-IPV/Hib) Conjugate Vaccine
-
CLINICAL_TRIALS study record update · 2019-06-27Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year-Old Children Previously Vaccinated With a 2-Dose or 3-Dose Infants Series and Toddler Dose With Vaxelis® or INFANRIX® Hexa
-
CLINICAL_TRIALS study record update · 2019-06-11Maternal Antibody in Milk After Vaccination
-
CLINICAL_TRIALS study record update · 2019-05-03An Open Label, Multicentric, Bridging Study to Assess the Safety of Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus Influenzae Type b Conjugate Vaccine (Adsorbed) Manufactured by Serum Institute of India Pvt. Ltd in Vietnamese Infants Aged 6-12 Weeks, Given as a 3-dose Regime, With 4 Week Intervals Between the Doses
-
CLINICAL_TRIALS study record update · 2019-03-22A Phase III/IV Randomised Open-label Study and Comparison of the Immunogenicity and Safety of a Single Adolescent Booster Dose of a Meningococcal Group C Conjugate-containing Booster Vaccine (Meningitec™, OR NeisVac-C™ , OR Menitorix™), When Given Concurrently With an Acellular Pertussis-containing Booster Vaccine (Repevax™ or IPV-Boostrix™)
-
CLINICAL_TRIALS study record update · 2018-12-17Seroprevalence of Bordetella Pertussis in Adults in Hungary
-
CLINICAL_TRIALS study record update · 2018-03-19An Open, Randomised, Comparative, Multicentre Study of the Immunogenicity and Safety of Concomitant Versus Separate Administration of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine (ProQuad®) and a Booster Dose of Infanrix® Hexa in Healthy Children 12 to 23 Months of Age
-
CLINICAL_TRIALS study record update · 2018-01-26The Feasibility of Pertussis Immunization in a Canadian Emergency Department
-
CLINICAL_TRIALS study record update · 2017-12-20Clinical Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) Safety in Pregnant Women
-
CLINICAL_TRIALS study record update · 2017-11-17To Evaluate the Role of Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan
-
CLINICAL_TRIALS study record update · 2017-10-09Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose